|
| Exchange Disseminated Time 01/02/2017 16:34:07 | Bliss GVS Pharma Ltd has informed BSE that the Board Meeting of the Company is scheduled to be held on February 09, 2017, inter alia, to consider the Un-Audited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31, 2016.
Further, Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation, 2015 read with the provision of the code of fair disclosure of the Company, the trading window of the Company will be closed from February 01, 2017 to February 11, 2017 (both days inclusive). |
|
|